Ethicon, Gmbh

Johnson & Johnson Consumer Inc.

Johnson and Johnson Vision Care, Inc.

Intarcia Therapeutics, Inc.

Other

Bristol-myers Squibb Compnay

Johnson & Johnson Consumer Companies, Inc.

Janssen Pharmaceutica Nv

Aruna Nathan

Joel S Rosenblatt

Steven C Arnold

Michael J Trezza, Ii

Susan Daly

Zhigang Li

Christopher G Levins

Catherine Manya Rohloff

Stephen A Berry

Joseph F Zavatsky

Han Cui

Ling-Ling Kang

Maureen J Borgia

Edgar V Menezes

Agis F Kydonieus

Anna Gosiewska

Ying Sun

Jeffrey M Wu

Walter R Laredo

Kishore R Shah

Jackie J Donners

Hassan Chaouk

Mora Carolynne Melican

Mark C Zimmerman

Kelly R Brown

Bret A Coldren

Marcus Eli Brewster

Veronique Preat

Louisa Myriam Ould-Ouali

Albertina Maria Arien

Michael J Ii Trezza

Joel Rosemblatt

A polymer composition comprising a linear ultraviolet radiation absorbing polyether that comprises a chemically bound UV-chromophore.

Ultraviolet radiation absorbing polyethers

A composition comprising: a benefit agent; at least one polymer including a poly(monostearoyl glycerol-co-succinate) polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent are disclosed.

Topical gel compositions including poly(monostearoyl glycerol-co-succinate) polymer and methods for enhancing the topical application of a benefit agent

The invention provides punctal plugs for the delivery of active agent to one or both of the tear fluid of the eye and to the nasolacrimal duct that comprise a body, at least one cap, and optionally a collarette.

Punctal plugs for the delivery of active agents

The present invention includes an ultraviolet radiation absorbing polymer composition that includes polymers containing a UV-chromophore, as described in the specification and as claimed the reaction product of a monoglyceride and a poly-acid monomer containing a UV-chromophore.

Ultraviolet radiation absorbing polymers

The invention provides punctal plugs for the delivery of active agent to one or both of the tear fluid of the eye and to the nasolacrimal duct. The plugs of the invention have a body, a reservoir contained within the body, and optionally a collarette. The reservoir has at least one opening and contains a polymeric material and at least one active agent.

The present invention is directed to medical devices and pharmaceutical compositions containing a synthetic, bioabsorbable, biocompatible liquid polymer that is the reaction product of a polybasic acid or derivative thereof, a polyol and a fatty acid, the liquid polymer having a melting point less than about 40&#xb0; C., as determined by differential scanning calorimetry.

Compositions and medical devices utilizing bioabsorbable liquid polymers

We have disclosed dicephalic amphiphiles having peptide sequences as the head groups. We have also disclosed self-assembly hydrogels prepared from the dicephalic peptide amphiphiles. These hydrogels are useful for the encapsulation and delivery of bioactives to a patient.

Self-assembling hydrogels based on dicephalic peptide amphiphiles

The invention provides devices useful for the delivery of active agents to the eye in a controlled manner. In the devices of the invention, the active agent is present within the device in a continuous or discontinuous concentration gradient.

Ophthalmic devices for the controlled release of active agents

Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.

Polyoxaester suspending vehicles for use with implantable delivery systems

The present invention is directed to medical devices or pharmaceutical compositions, each containing a synthetic, bioabsorbable, biocompatible polymer that is the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a polyether.

Amphiphilic polymers for medical applications

The present invention is directed to synthetic, biodegradable, biocompatible polymers that are the reaction product of an &#x3b1;,&#x3b2;-unsaturated polybasic acid or derivative thereof and a monoglyceride, and which further contain pended thereto a functional agent, and to medical devices and compositions containing such polymers.

Functionalized polymers for medical applications

The present invention is directed to medical devices and pharmaceutical or agricultural compositions, and seeds, each containing a synthetic, bioabsorbable, biocompatible polymeric wax that is the reaction product of a polybasic acid or derivative thereof, a polyol and a fatty acid, the polymeric wax having a melting point less than about 70&#xb0; C., as determined by differential scanning calorimetry, and an effective amount of rapamycin or an analogue thereof.

Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin

Growing community of inventors

Bridgewater, NJ, United States of America

Aruna Nathan